TP53 and neoplasm: TP53 mutations in the germline of Li Fraumeni patients and in sporadic cancer, are mostly missense mutations that occur in the DNA-binding domain resulting in loss of tumor suppressor function and in some cases, gain of oncogenic functions2–4.